seed
Stage
1
Investors
About
Dayhoff Labs develops AI-driven artificial biology platforms that model and orchestrate molecular networks and catalytic biochemical processes to enable applications in pharmaceutical manufacturing, agriculture, energy, industrial chemistry, biosensing, and novel computation.
Explore Dayhoff Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.